NSE filing, NSE: LENSKART. Summary written from the filing by ALFA Finder's alert engine.
Lenskart Solutions Ltd: key numbers
- Share price
- ₹688.35
- Market cap
- ₹1,19,685 Cr
- Revenue (annual)
- ₹8,814 Cr
- Net profit (annual)
- ₹493.6 Cr
- P/E (TTM)
- 182.6×Sector 49.5×
- Promoter holding
- 17.52%-0.01% QoQ
- FII holding
- 18.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lenskart Solutions Ltd
All →Lenskart Solutions Board Meeting Date
Lenskart Solutions Limited scheduled a board meeting for November 4, 2026, to consider and approve its unaudited standalone and consolidated financial results for the September 2026 quarter.
Lenskart Solutions Legal & Regulatory
Lenskart Solutions Limited received a customs duty demand and penalty order totaling ₹13.17 Crore. The Company intends to challenge this order-in-original regarding the classification of imported optical eyeframes.
- Value
- ₹13.17 Cr
- From
- Office of the Principal Commissioner of Customs
Lenskart Solutions Employee Stock Options
Lenskart Solutions Limited granted 3,42,000 employee stock options to eligible employees, with an exercise price of Rs. 508 per share under its 2021 ESOP plan.
Lenskart Solutions Acquisition Worth ₹2.71 Cr
Lenskart's subsidiary, NESO Brands, acquired an additional 2.52% stake in Le Petit Lunetier Paris SAS for INR 2.71 Crore. This strategic move expands its brand portfolio.
- Value
- ₹2.71 Cr
Lenskart Solutions Capital Structure Change
Platinum Jasmine A 2018 Trust sold 3.5 crore on-market Lenskart shares, reducing stake from 9.77% to 7.75%. No transaction price disclosed.
Lenskart Solutions Earnings Call Transcript: Key Takeaways
Lenskart reported a record-breaking Q3 FY26, surpassing 20% EBITDA margins for the first time.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.